## USB: U.S. Bancorp - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.1% below STRENGTH zone (3.0-6.0%); PEG 1.60 fails VALUE criteria (<1.0); RSI 73 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (73).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($49.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Amundi Reduces Stock Position in U.S. Bancorp $USB**
- Source: MarketBeat | 20251207T081806 | Neutral | Relevance: 99%
-  Amundi significantly reduced its stake in U.S. Bancorp (NYSE:USB) by 75.6% during the second quarter, selling over 15 million shares and now owning 0.31% of the company. Despite Amundi's reduction, other institutional investors like Norges Bank and Davis Selected Advisers increased their holdings in USB. The article also details recent insider selling by U.S. Bancorp executives and provides financial performance data and analyst ratings for the company.

**2. Natixis Acquires 431,041 Shares of U.S. Bancorp $USB**
- Source: MarketBeat | 20251208T122547 | Bullish | Relevance: 98%
- Natixis significantly increased its stake in U.S. Bancorp by 86.1% in Q2, acquiring 431,041 shares to hold a total of 931,398 shares valued at approximately $42.15 million. This comes as U.S. Bancorp outperformed Q3 earnings estimates with $1.22 EPS on $7.34 billion revenue and raised its quarterly dividend to $0.52. Institutional interest in the company remains high, with a consensus analyst target price of $54.45, indicating a "Moderate Buy" rating.

**3. CW Advisors LLC Increases Stock Position in U.S. Bancorp $USB**
- Source: MarketBeat | 20251206T091112 | Bullish | Relevance: 98%
-  CW Advisors LLC significantly increased its stake in U.S. Bancorp (NYSE:USB) by 64.9% in Q2 2025, now holding 119,983 shares valued at approximately $5.43 million. This comes as U.S. Bancorp positively beat Q3 earnings estimates, reporting $1.22 EPS against a $1.11 consensus and $7.34 billion in revenue, and increased its quarterly dividend to $0.52. Institutional interest remains strong, with Norges Bank establishing a large position and Vanguard Group being a major shareholder, contributing to a "Moderate Buy" analyst consensus with an average target price of $54.45.

**4. United States - Sheppard Mullin Advises U.S. Bank In Tax Equity Investment In Arkansas Wind Project**
- Source: Mondaq | 20251208T150844 | Somewhat-Bullish | Relevance: 97%
-  Sheppard Mullin's Energy, Infrastructure and Project Finance team advised U.S. Bancorp (NYSE: USB) on a $263 million tax equity investment in Cordelio Powerâ€™s Crossover Wind project in Cross County, Ark. This 135 MW project is Arkansas's first utility-scale wind venture and is now commercially operational. The investment helps U.S. Bank's client expand renewable energy sources, strengthen the energy grid, and create local jobs.

**5. Federated Hermes Inc. Buys 445,694 Shares of U.S. Bancorp $USB**
- Source: MarketBeat | 20251207T121232 | Bullish | Relevance: 97%
- Federated Hermes Inc. increased its stake in U.S. Bancorp (NYSE:USB) by 4.7% during the second quarter, acquiring an additional 445,694 shares, bringing its total holdings to 9,931,308 shares valued at approximately $449.4 million. Despite this institutional buying, corporate insiders, including Chairman Andrew Cecere and EVP James L. Chosy, have recently sold significant portions of their shares. U.S. Bancorp reported strong Q3 earnings, beating analyst estimates, and increased its quarterly dividend, while analysts maintain a "Moderate Buy" rating with an average target price of $54.45.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-19 | Oppenheimer | $64 | $66 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-19 | Oppenheimer | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($1.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (+0.9%)
- Blackrock Inc.: 8.3% (-1.8%)
- JPMORGAN CHASE & CO: 5.8% (+117.8%)
- FMR, LLC: 4.6% (+0.9%)
- State Street Corpora: 4.4% (+0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +1.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.60 elevated, pricing in significant growth expectations. Quality metrics strong (margin 28%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($1.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $80.0B |
| Beta | 1.11 |
| 52W Range | $35.18 - $52.27 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.60 |
| Forward P/E | 10.5 |
| Current P/E | 11.3 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.9% to 2.1% (+1.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.9pp (needs >3.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 73, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.13% (CS: 75) | Neutral |
| RSI_14 | 73.1 | Overbought |
| MACD Histogram | 0.42 | Bullish |
| vs SMA20 | 1.061x | Above |
| vs SMA50 | 1.079x | Above |
| vs SMA200 | 1.136x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $51.41
- **Stop Loss:** $49.55 (3.6% risk)
- **Target:** $53.27 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 537
- **Position Value:** $27,607.17
- **Portfolio %:** 27.61%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-20 (Est: $1.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.12 | $1.22 | +9.0% |
| 2025Q2 | $1.07 | $1.11 | +4.1% |
| 2025Q1 | $0.97 | $1.03 | +5.7% |
| 2024Q4 | $1.05 | $1.07 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*